1. Home
  2. GNK vs ARCT Comparison

GNK vs ARCT Comparison

Compare GNK & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNK
  • ARCT
  • Stock Information
  • Founded
  • GNK 2004
  • ARCT 2013
  • Country
  • GNK United States
  • ARCT United States
  • Employees
  • GNK N/A
  • ARCT N/A
  • Industry
  • GNK Marine Transportation
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNK Consumer Discretionary
  • ARCT Health Care
  • Exchange
  • GNK Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • GNK 707.2M
  • ARCT 602.7M
  • IPO Year
  • GNK 2005
  • ARCT N/A
  • Fundamental
  • Price
  • GNK $17.67
  • ARCT $16.02
  • Analyst Decision
  • GNK Strong Buy
  • ARCT Strong Buy
  • Analyst Count
  • GNK 6
  • ARCT 7
  • Target Price
  • GNK $24.20
  • ARCT $65.00
  • AVG Volume (30 Days)
  • GNK 525.6K
  • ARCT 400.2K
  • Earning Date
  • GNK 11-06-2024
  • ARCT 11-07-2024
  • Dividend Yield
  • GNK 7.70%
  • ARCT N/A
  • EPS Growth
  • GNK 527.82
  • ARCT N/A
  • EPS
  • GNK 1.58
  • ARCT N/A
  • Revenue
  • GNK $439,330,000.00
  • ARCT $160,399,000.00
  • Revenue This Year
  • GNK $15.24
  • ARCT $13.02
  • Revenue Next Year
  • GNK N/A
  • ARCT $5.58
  • P/E Ratio
  • GNK $11.14
  • ARCT N/A
  • Revenue Growth
  • GNK 11.14
  • ARCT N/A
  • 52 Week Low
  • GNK $14.03
  • ARCT $14.93
  • 52 Week High
  • GNK $23.43
  • ARCT $45.00
  • Technical
  • Relative Strength Index (RSI)
  • GNK 59.05
  • ARCT 31.24
  • Support Level
  • GNK $17.32
  • ARCT $18.90
  • Resistance Level
  • GNK $17.91
  • ARCT $21.61
  • Average True Range (ATR)
  • GNK 0.35
  • ARCT 1.15
  • MACD
  • GNK 0.23
  • ARCT -0.07
  • Stochastic Oscillator
  • GNK 76.08
  • ARCT 16.32

About GNK Genco Shipping & Trading Limited New (Marshall Islands)

Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

Share on Social Networks: